Progesterone compositions for treating endometriosis
OA: closed
AI-generated summary
The invention utilizes 16-methylene-17 alpha-acetoxy-19-nor-progesterone to manufacture pharmaceutical compositions for treating endometriosis and other estrogen-dependent conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The invention concerns the use of 16-methylene-17 alpha -acetoxy-19-nor-progesterone for the manufacture of a pharmaceutical composition for the treatment of endometriosis and other estrogen-dependent conditions.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-24T06:18:32.875334+00:00